Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance

• Главные авторы: Francisca Villanueva-Flores (Автор), Andrés Zárate-Romero (Автор), Alfredo G. Torres (Автор), Alejandro Huerta-Saquero (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2021-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Asparaginase (ASNase) is a widely applied chemotherapeutic drug that is used to treat Acute Lymphoblastic Leukemia (ALL); however, immune responses and silent inactivation of the drug often limit its bioavailability. Many strategies have been proposed to overcome these drawbacks, including the devel...